Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
The decision gives patients another option for joint and skin symptoms tied to the autoimmune disease. The U.S. Food and Drug Administration approved the drug after reviewing late-stage trial data that showed better disease control than placebo, according to a PRNewswire release. The treatment works by selectively targeting tyrosine kinase 2, a pathway involved in immune-driven inflammation. Don't Miss: Explore the Fire-Safe Energy Storage Company With $185M in Contracted Revenue The ‘ChatGPT of Marketing' Just Opened a $0.85/Share Round — 10,000+ Investors Are Already In Clinical Trial Results Researchers tested the drug in two global Phase 3 studies, POETYK PsA-1 and POETYK PsA-2. Patients received either a daily 6-milligram tablet or placebo during the controlled part of the trials. Investigators used American College of Rheumatology response criteria to measure results. By Week 16, about 54% of patients taking Sotyktu achieved an ACR20 response in both studies.
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb Tests New Protein Degradation Cancer Drug In Humans [Yahoo! Finance]Yahoo! Finance
- BioIVT to Showcase ADME-Tox and NAMs Expertise at Spring 2026 Industry Events [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026Business Wire
- Don't Miss This 14% Yield And This Pharma Value Stock [Seeking Alpha]Seeking Alpha
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- BMY's page on the SEC website